Microelimination targets specific subpopulations and/or geographic settings for hepatitis C
virus (HCV) elimination. This review reports on global HCV microelimination literature …

Abstract The World Health Organization has set a goal to eliminate hepatitis C virus (HCV)
infection as public health threat by 2030. Although the advent of highly effective and …

There have been major strides towards the World Health Organization goal to eliminate
hepatitis C virus (HCV) infection as a global public health threat. The availability of simple …

Background With the advent of low‐cost generic direct‐acting antivirals (DAA), hepatitis C
(HCV) elimination is now achievable even in low‐/middle‐income settings. We assessed the …

Background The prevalence of chronic hepatitis C (CHC) in People Who Inject Drugs
(PWID) is 8-10% as compared to 3· 6% in the general population in Punjab, India. We …

There has been an increase in the burden of liver diseases in Iran, with an increasing trend
from communicable to non-communicable diseases. Almost 5400 deaths were due to …

This study aimed to identify the factors associated with timely (within four weeks) HCV RNA
testing and timely (within six months) DAA initiation following HCV notification in the DAA …

Abstract Background Hepatitis C virus (HCV) treatment through primary care and community‐
based services will be a critical component of HCV elimination. We evaluated a nurse …

Background Elimination of hepatitis C virus (HCV) among people who use drugs (PWUD)
remains a challenge even in countries in which HCV care is provided free of cost. We …

Background and aim People who inject drugs are at high risk of contracting hepatitis C
(HCV). The introduction of direct acting antiviral (DAA) drugs to treat HCV has the potential …